US 8722895
Prolyl hydroxylase inhibitors and method of use
granted A61KA61K31/4418A61K31/4433
Quick answer
US patent 8722895 (Prolyl hydroxylase inhibitors and method of use) held by Akebia Therapeutics, Inc. expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Akebia Therapeutics, Inc.
- Grant date
- Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4418, A61K31/4433, A61P, A61P1/04